4.7 Review

Biology and Management of Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma, and Malignant Peripheral Nerve Sheath Tumors: State of the Art and Perspectives

期刊

JOURNAL OF CLINICAL ONCOLOGY
卷 36, 期 2, 页码 160-+

出版社

AMER SOC CLINICAL ONCOLOGY
DOI: 10.1200/JCO.2017.75.3467

关键词

-

类别

资金

  1. PharmaMar
  2. GlaxoSmithKline
  3. Novartis
  4. MSD
  5. AstraZeneca
  6. NATIONAL CANCER INSTITUTE [ZIASC010354] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Undifferentiated pleomorphic sarcomas, myxofibrosarcomas, and malignant peripheral nerve sheath tumors are characterized by complex genomic characteristics and aggressive clinical behavior. Recent advances in the understanding of the pathogenesis of these tumors may allow for the development of more-effective innovative therapeutic strategies, including immunotherapies. This review describes the current knowledge of the epidemiology, clinical presentation, treatment, and pathogenesis of these tumors and highlights ongoing and future research. (c) 2017 by American Society of Clinical Oncology

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据